Ditch Labs is a Canadian digital health startup founded in 2019, with a noteworthy slogan of pioneering nicotine addiction treatment using artificial intelligence and a revolutionary device. The company focuses on addressing both physiological and psychological addiction through a proprietary medical device and digital therapeutic application. In July 2023, Ditch Labs secured a significant $3.50M Seed Round investment from a diverse group of investors including Anges Québec, Capital Angel Network, Amplify Capital, Investissement Québec, The Kale Fund, Boreal Ventures, Meditrial, and Symphony Care Network.
The company operates in the Health Care and Pharmaceutical industries, demonstrating its potential to contribute to these critical sectors. The recent investment signifies the confidence of several well-established investment firms in the vision and capabilities of Ditch Labs. With this backing, the company can further develop its innovative approach and make significant strides in the treatment of nicotine addiction, which remains a pressing public health issue. Ditch Labs has positioned itself as a promising player in the digital health space, leveraging technology and medical innovation to address a widespread and challenging health concern.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $3.50M | 8 | Kale Investment Fund | 12 Jul 2023 |
Grant | $20.00K | 1 | The Bourse+ | 27 Apr 2023 |
Seed Round | $350.00K | 1 | 14 Feb 2022 | |
Pre Seed Round | Unknown | 1 | 21 Jun 2021 | |
Pre Seed Round | $1.30M | 8 | Simon De Baene, Desjardins Financial Security Investments +1 | 01 May 2021 |
No recent news or press coverage available for Ditch Labs.